COSCIENS Biopharma Inc.
Research COSCIENS Biopharma Inc. (CSCI) on Bullrun: market cap CAD 10.32M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCSCI
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 10.32M
- Financial periodQ4 2025
- RevenueCAD 1.77M
- Net income-CAD 2.18M
- Free cash flow-CAD 1.52M
- Gross margin34.5%
Valuation Snapshot
latest market cap is CAD 10.32M.
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides;
Frequently asked questions
What is COSCIENS Biopharma Inc.'s market cap?
COSCIENS Biopharma Inc.'s market capitalization is CAD 10.32M.
What does COSCIENS Biopharma Inc. do?
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments.